Organisation paid for research Program year 2025 Source: CMS Open Payments

Wssaai/Asthma

Neither a doctor nor a teaching hospital

Research payments

$114,722

7 payments

Through program year 2025, Wssaai/Asthma is reported as receiving $114,722 in research payments, across 7 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $10,107 1
2024 Research $8,254 1
2023 Research $25,043 1
2022 Research $37,092 2
2021 Research $26,152 1
2020 Research $8,074 1

Breakdown

Who paid Research payments · program years 2020–2025
  1. AstraZeneca Pharmaceuticals LP $114,722 7 payments
Studies the money was for Research payments · program years 2020–2025
  1. A Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in Patients Receiving Standard of Care Therapy $114,722 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record